Inventor · disambiguated record
Hermann Lubbert
Also filed as: LUBBERT HERMANN · LUEBBERT HERMANN · LÜBBERT HERMANN
11 granted patents·7 pending applications·58 citations·filing 1999–2024
87Inventor score
Top patents by PatentIndex Score
18 records- 0194USD1021120SLED panel for a photodynamic therapy lampBIOFRONTERA PHARMA GMBH·Filed 2021·Granted Apr 2, 2024·8 cites·1 claims
- 0294US11235169B1Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination deviceBIOFRONTERA PHARMA GMBH·Filed 2021·Granted Feb 1, 2022·12 cites·20 claims
- 0393US11219781B2Illumination for photodynamic therapyBIOFRONTERA PHARMA GMBH·Filed 2021·Granted Jan 11, 2022·6 cites·14 claims
- 0488US7060711B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2002·Granted Jun 13, 2006·24 cites·10 claims
- 0576US2025249276A1Illumination for photodynamic therapyBIOFRONTERA PHARMA GMBH·Filed 2024·Application pending·0 cites
- 0671US11642411B2Photodynamic therapy comprising two light exposures at different wavelengthsBIOFRONTERA BIOSCIENCE GMBH·Filed 2018·Granted May 9, 2023·1 cites·20 claims
- 0765USD1052103SPhotodynamic therapy lamp headBIOFRONTERA PHARMA GMBH·Filed 2022·Granted Nov 19, 2024·3 cites·1 claims
- 0859USD1067446SPhotodynamic therapy lampBIOFRONTERA PHARMA GMBH·Filed 2022·Granted Mar 18, 2025·2 cites·1 claims
- 0956US7511064B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2006·Granted Mar 31, 2009·0 cites·21 claims
- 1055US12208278B2Illumination for photodynamic therapyBIOFRONTERA PHARMA GMBH·Filed 2019·Granted Jan 28, 2025·0 cites·21 claims
- 1148US2023390573A1Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination deviceBIOFRONTERA PHARMA GMBH·Filed 2021·Application pending·0 cites
- 1245US12472374B2Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination deviceBIOFRONTERA PHARMA GMBH·Filed 2020·Granted Nov 18, 2025·0 cites·22 claims
- 1337US2003219807A1Multiple genes relevant for the characterization, diagnosis, and manipulation of strokeFiled 2003·Application pending·0 cites
- 1437US2003022920A11-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonistFiled 2002·Application pending·0 cites
- 1536US2003216341A1Multiple genes relevant for the characterization, diagnosis, and manipulation of neuropathic painFiled 2003·Application pending·0 cites
- 1635US2003212003A1Cathepsin Y for the development of a medicament for the treatment of painFiled 2003·Application pending·0 cites
- 1729US2003232740A1Cathepsin Y for the development of a medicament for the treatment of strokeFiled 2003·Application pending·0 cites
- 1821US6670121B1Methods for characterizing mRNA moleculesBIOFRONTERA PHARMACEUTICALS GM·Filed 1999·Granted Dec 30, 2003·2 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →